Annual Drug Patent Expirations for AMVUTTRA
Amvuttra is a drug marketed by Alnylam Pharms Inc and is included in one NDA.
The generic ingredient in AMVUTTRA is vutrisiran. Additional details are available on the vutrisiran profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
